Bristol Myers Stock-Based Compensation — Historical Data
Bristol Myers (BMY) stock-based compensation was $553M in FY2025 (+9% YoY). The tables below show the complete quarterly and annual stock-based compensation history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Stock-Based Compensation
Fiscal Year
Stock-Based Compensation
YoY
2025
$553M
+9%
2024
$507M
-2%
2023
$518M
+13%
2022
$457M
-22%
2021
$583M
-25%
2020
$779M
+77%
2019
$441M
+100%
2018
$221M
+11%
2017
$199M
-3%
2016
$205M
-13%
2015
$235M
+10%
2014
$213M
+12%
2013
$191M
-23%
2012
$248M
+54%
2011
$161M
-17%
2010
$193M
+5%
2009
$183M
+1%
2008
$181M
+36%
2007
$133M
Recent Quarterly Stock-Based Compensation
Quarter
Stock-Based Compensation
Q2 2026
$135M
Q1 2026
$146M
Q4 2025
$133M
Q3 2025
$139M
Q2 2025
$138M
Q1 2025
$144M
Q4 2024
$120M
Q3 2024
$129M
Q2 2024
$125M
Q1 2024
$133M
Q4 2023
$127M
Q3 2023
$132M
Source: BMY on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.